1. Katoh, Masuko, Katoh, Masaru. . Human FOX gene family (Review). In International journal of oncology, 25, 1495-500. doi:. https://pubmed.ncbi.nlm.nih.gov/15492844/
2. Yu, Yang, Cao, Wen-Ming, Cheng, Feng, Zhang, Chunchao, Zhang, Hong. 2024. FOXK2 amplification promotes breast cancer development and chemoresistance. In Cancer letters, 597, 217074. doi:10.1016/j.canlet.2024.217074. https://pubmed.ncbi.nlm.nih.gov/38901667/
3. Zhang, Yaqi, Wang, Yinu, Zhao, Guangyuan, Adli, Mazhar, Matei, Daniela. . FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway. In The Journal of clinical investigation, 132, . doi:10.1172/JCI151591. https://pubmed.ncbi.nlm.nih.gov/35349489/
4. Nagel, Stefan, Pommerenke, Claudia, Quentmeier, Hilmar, Kaufmann, Maren, MacLeod, Roderick A F. 2022. Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma. In Biomedicines, 10, . doi:10.3390/biomedicines10082038. https://pubmed.ncbi.nlm.nih.gov/36009586/
5. Wang, Xi-Wen, Guo, Qi-Qiang, Yu, Yang, Zhao, Jun-Gang, Cao, Liu. 2021. The deacetylation of Foxk2 by Sirt1 reduces chemosensitivity to cisplatin. In Journal of cellular and molecular medicine, 26, 491-506. doi:10.1111/jcmm.17107. https://pubmed.ncbi.nlm.nih.gov/34866322/
6. Li, Yingge, Chen, Jie, Wang, Bin, Pei, Huadong, Yao, Yi. 2023. FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis. In Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 67, 100926. doi:10.1016/j.drup.2023.100926. https://pubmed.ncbi.nlm.nih.gov/36682222/
7. Feng, Haoran, Jin, Zhijian, Liang, Juyong, Cheng, Xi, Qiu, Weihua. 2021. FOXK2 transcriptionally activating VEGFA induces apatinib resistance in anaplastic thyroid cancer through VEGFA/VEGFR1 pathway. In Oncogene, 40, 6115-6129. doi:10.1038/s41388-021-01830-5. https://pubmed.ncbi.nlm.nih.gov/34489549/
智鼠故事 
